{"ticker": {"uuid": "439fe485-a409-46e2-a81f-f4bed6951fd5", "symbol": "VRTX34", "name": "Vertex Pharmaceuticals Incorporated", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Vertex Pharmaceuticals stock hits 52-week high at $507.98", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWUVETE9JTW1qaXUwTUQxUmFuUngtTS0xeFpDTGF0QkZDTGluTVR4eWU1RzlvUEYwcGdaY1g0eU05aDNMaW5NNUR3NnhtY0NiZmQzMlhkaFBvaWJjTllreFQ1d0ZFMko2TGszOUh2bkk2bkRBZHhvZEVJakNWczE2WmZ2ekk2YVhwdE9lcnBhNDAzUWxZVXhPeWU1NHdyYm0tS3IzN3RWYkRLRGw2cEJlRg?oc=5", "source_name": "Investing.com", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOcGllVHJ4LXo0RDZmSlFiQ2wzUTZtRXU1V0xpeFh4SjE1R050Z1BHbEpGR3hIZTRQVDJVdXRoekJFX0VOVGZZbjNpTlR5WnVtYVo4LUlHVkptRGVRSlVWLXJ2dVJnLTdkOHlaOFo3TVF1OEJGSi1XZmtQdkJDNVlkQkY4UEFvaFhYeXY4QVpTU1pDVHRBYU1KWXRyck5QazlkenAtdmMwSnFrYXA3WVlBWVVrcnNSdUZlZ0NqVjFNYXBsUQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Joy Liu Sells Shares of Vertex Pharmaceuticals Inc (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQUZZdzFSNmRUa2lPN1Q1dWJQRGR2cXdaUFd1SUdsczhMTl9JN05wVG9VZkh2YzQ1dC1yc3BOM3hxVjd0TGRGYWt5aWlHMUtWMS14TVRzS0dFWHhqcFlsN2lndlA2aFJOeThyR0xVWnlFSm5QcWJ0VFNjd2xiVGpWSXRhN2xUTWluZjN6OVZLM2lwSlRrbFdZYWt2aVNMNUNCOWZjWUxvSnNYUExlbUZHbVZpc3VCYXBTZzNr?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals\u2019 SWOT analysis: kidney drug stock draws mixed views", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOTWw5U2RCbms5WmQ3MUdwTGFMOG5LNU1OSDNmNkFwb3B5UTl3THFhQlNCRi1CNWVjaTJodl9qa0dCZnRvVHZTY250c3QxNG40RkVDaUZSdV9YSjBwcGlldzg1aHlqRGx5QXNDeTVGQ3FSOHU2YWI0TGt1aXhwQm1GU01mSWxoNGJsdjY5Q1I4UHB1R2ZpY2h4VE5pckVpLVltQTdpSmRnbDV0OHJiQUNsQXNuVjNzTWJ5X0RTbFNBU3FwUzJVRDFwUw?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNQ2ROSzJaeDBkY3I0bjRrYkhQbDJTenlKaFBidzNjWkxndk5pME9ILXVRNUYxdUlGMmdpcmhkZmRxaU1qUG50MXNSWm40bFZPZ0IxTG1LOWdvM0JNTWNkVkFLdWdBYkxueHZ2WWdTZUlfTEdtcDVoVEZ2dlotczcxTXg0RVFra25ZYVVpbXp2dWV4MWhkZ0k4RnZnVXhMZWRQb3U1ck1xWU9YNDRDZkRTUkFJNDJ3dEM5WFJWcWxPR3VqTVpjaGc?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock rallying today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSW1nRnNlajFzc2VkREJqbTJwV2pyNjd0UTdEcHlGblZEamltS0piMlAyRDBuTXA4ekVZVnpRbjRLQW04TjlaUWRnWndWYm9Bb2F3ZGI3cU5HQnd6Qk5kMk5WSVpUc1h0bVBMNDh4R0lXX3drNkVjSVFRNms0ZTFIM1p5NTVvTVJFa18zWHZPQWZIUm5UNE5LaXlNLXRjRXktQzFjMWVMZDN3T19LZnl2dA?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals EVP Joy Liu sells $469,222 in shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQd1BUaVF4Q3duR0RPQlI2TmtTcU5iS2huOUJKZm91ZEp6ZjRTcThTd0xiM1F5T2hVLW54ZHpsWF9aaVVHNkwxTzJOd2RqQ3cwNjEySTJSTDU1MHljZFRia2JXQ3RXd3dYaVAxN0pMRmZhejJDUVpMbFBjVjk0dkZYYXFaQW5IT1RlS1dkMkV4MzVFV0FYX2pFSzB0UnVrSHNGcG9UWnJmUS1RcC0tRXNpUXpTa1h4RGlCV0Zndko5MA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma posts mixed Q1 results; Shares edge lower", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOLU5xNl9JNXNnNFFJNWtxNjdRSFROQnlhZnN0S1Fkd1drWWFGb1FXLXA4Qk1naTJSeTQxNHFURzdDMWh0amVTS3l0WVdPSHdnT2dzc0VFazZVbkFQdks2WTF1eGxwSm9pT2lpSEltT3FQUnFHQUNhT0hyWkJsam5fVl84dENxbjB3WVJoUzJwMTdtRllDQkE2VUhxd3RtWWFfeXdQNVYzXy1QemM?oc=5", "source_name": "Investing.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What to Expect From Vertex Pharmaceuticals\u2019 Q1 2026 Earnings Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPaDlwdnJpS3dqeVA5a3hpQUZoUHhkNGItLTRvN21LVTJmWnNpUl9La0NQc1pDTV9kVGlTTTllUmdOdjQ0bzdEQkJKVXlYYy01ZEdOS1REUW9ZUTgyMlZqZ0JwWW1ITExFSzlWSG02TDdSNk1ubHEwa3hiSzJzX2d3MllrcFAtV0JvMHJobmxFb2swcEZNcXFVdnRRWk5PRk4tcy1hRDdySWdsVXM4dnVF?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argus raises Vertex stock price target to $520 on CF franchise", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPdERMSmVmcWRudlgyNm5VcURWU2tkUFlhYWFmY0tFcUluNnpPQ012Sm5pdWdHcDFQLVJDVXlBZDdPQVZEaEZORzNjMzROdEpTcXE0WWtOaWNfQVRwSGEzYVo4RVNVcW9GTmxsUVNTY1AtRzdKYVZpUjNrWF9OZnpnSDdIMGVBUXJYc3hsRjlpbkdKUHozYVhTN0RUd0FFS1NmSlRFaV8wV0RvZ012VUFRTlFlRjhoWHduOVRNaVp3?oc=5", "source_name": "Investing.com", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital reiterates Vertex stock rating on competitive concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQbW5PMng3cWd5ekZkZ3NnNnBIamJlVElqT0Z2SVBCWVl3MDdpclZFT3pGbnVSd1BXWG5odlZfUHJNaWg5MDhQdm5MakZSdnE2bk81TWlHR0xYRk9HdGl5bUdONm1objk3cXluRzBQbXpxMGprcEJaSXo2QkZkU1ZqNWtwLUF1eXYyS3F0Ny1vMEw2V3M2NW9RYm1mLW1zbVczcGMzRFJOT19lUzdORzJvaU52ck83VFV0Z3dzbnBxR3JQVW0z?oc=5", "source_name": "Investing.com", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Jumps with Positive Drug Pipeline News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPX1Z0eFhMcGFXeG1VeVBuZkYtQVR0NmlCZmlyUUFwOV9tdzlhV3NIUzZ6SWY1dC1seElmMF8yUzYyUk9NTkZES0tiNG9neHM1S0VuazdUc3labkVzUk9DMC1aWjJNd0pBX05ZTzZUNHh4VHVVdGNBQVE3ZzlIbmFjaVl0bThxdFVzXzJ1NGpJa1I2cjBaZ3FCOQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Duncan Mckechnie Sells Shares of Vertex Pharmaceuticals Inc (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOenJUb19adXZRZFpxZ1lOVldBNENSUWRLaFc5SjRhcWF0TzJ4WmNBdldmcWd2YWMtVExaTk42aHdtcldSeUNOQVhfZ1hFR2tSTmMxLUw2NlN4VmdJZ0VTcnZTZ2xvbEk3Mi1pR2ZDLW9xOU5EeWpOYWVQZ1ZhUjhPd054Z0dXWlRwTlIxVXlKa0RMdG53OEtVNHEwMjBnRkZLeDlXamdrVDRMa1pUSDdiSml5a2pHZU9Yc2pEWmhMMGY5MHE5bEZN?oc=5", "source_name": "GuruFocus", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ambrose, Vertex Pharmaceuticals SVP, sells $108k in VRTX stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOMExaVEwyX3NRVFZVTUFSaFhBVTNLa2lnOG5OZ2I4bkFmTFdzZXBxeHdpWUpmN3B0d1ZSdTlSS0lWQWYwUkw4cTVNQ0llVFdGR3hFLXdCajl4TGt1VVQxb1I0VzdRZXZ1Skt3dlNwelVCZkNKZS1RbnRFYmtLSkVBQ2lnenAxQlA1d0pyYkxrenhrc2liZ1VoalBsVlZhWkNHRmhzRnZWUFkzWlROak5FU0pGUm9pRUtqaHRqX3l1UGhsQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) (NASDAQ:VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMmxYWmJfSEZ6cHFraDJySHJPZzVJckFmYjBWZFVReDU3UXBva01yTU9hcWRLdVl3WnVUS1kxZENPNW1xR0t0Y05SRi1JYkg1VzM2ck55V0p6dzU5SGpuem1CcU1PSkZCcVByMVdjc0hQX3ZqTkVwX3M2Vlg5U3UzelkyM0thVGFmS0VaM01mTFZMRFhZWjRXWDFjbFVvdGpPM196bGl3U3VubjQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5", "source_name": "Investing.com", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOcGl1VW1CbE5Oc1h2cEhKNEU0cXhqX2sxdnhUVlRfZFROT1JXc2dDRzJ1M3JPckh4UzZWblFOeE5lNmhpQld5bDhXYTJvNGlXaTNQMjdXOVhSeS1jU045TzRkYV9WWnZaRnR1R1ppamxhbG14cjY0V2FOdzNRcGRkVGROcnJLYjQtRTBnUm5zd0gzY3BYYmtZVGRQLWlCVmZKWWk3UHdBYWZPZDNjOEhsZlVtSUlmQkxDUGo1czlwSlhBN0RNNXhV?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-10-24T07:00:00+00:00", "published_display": "24 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vertex Pharmaceuticals stock hits 52-week high at $507.98", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWUVETE9JTW1qaXUwTUQxUmFuUngtTS0xeFpDTGF0QkZDTGluTVR4eWU1RzlvUEYwcGdaY1g0eU05aDNMaW5NNUR3NnhtY0NiZmQzMlhkaFBvaWJjTllreFQ1d0ZFMko2TGszOUh2bkk2bkRBZHhvZEVJakNWczE2WmZ2ekk2YVhwdE9lcnBhNDAzUWxZVXhPeWU1NHdyYm0tS3IzN3RWYkRLRGw2cEJlRg?oc=5", "source_name": "Investing.com", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOcGllVHJ4LXo0RDZmSlFiQ2wzUTZtRXU1V0xpeFh4SjE1R050Z1BHbEpGR3hIZTRQVDJVdXRoekJFX0VOVGZZbjNpTlR5WnVtYVo4LUlHVkptRGVRSlVWLXJ2dVJnLTdkOHlaOFo3TVF1OEJGSi1XZmtQdkJDNVlkQkY4UEFvaFhYeXY4QVpTU1pDVHRBYU1KWXRyck5QazlkenAtdmMwSnFrYXA3WVlBWVVrcnNSdUZlZ0NqVjFNYXBsUQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Joy Liu Sells Shares of Vertex Pharmaceuticals Inc (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQUZZdzFSNmRUa2lPN1Q1dWJQRGR2cXdaUFd1SUdsczhMTl9JN05wVG9VZkh2YzQ1dC1yc3BOM3hxVjd0TGRGYWt5aWlHMUtWMS14TVRzS0dFWHhqcFlsN2lndlA2aFJOeThyR0xVWnlFSm5QcWJ0VFNjd2xiVGpWSXRhN2xUTWluZjN6OVZLM2lwSlRrbFdZYWt2aVNMNUNCOWZjWUxvSnNYUExlbUZHbVZpc3VCYXBTZzNr?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals\u2019 SWOT analysis: kidney drug stock draws mixed views", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOTWw5U2RCbms5WmQ3MUdwTGFMOG5LNU1OSDNmNkFwb3B5UTl3THFhQlNCRi1CNWVjaTJodl9qa0dCZnRvVHZTY250c3QxNG40RkVDaUZSdV9YSjBwcGlldzg1aHlqRGx5QXNDeTVGQ3FSOHU2YWI0TGt1aXhwQm1GU01mSWxoNGJsdjY5Q1I4UHB1R2ZpY2h4VE5pckVpLVltQTdpSmRnbDV0OHJiQUNsQXNuVjNzTWJ5X0RTbFNBU3FwUzJVRDFwUw?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNQ2ROSzJaeDBkY3I0bjRrYkhQbDJTenlKaFBidzNjWkxndk5pME9ILXVRNUYxdUlGMmdpcmhkZmRxaU1qUG50MXNSWm40bFZPZ0IxTG1LOWdvM0JNTWNkVkFLdWdBYkxueHZ2WWdTZUlfTEdtcDVoVEZ2dlotczcxTXg0RVFra25ZYVVpbXp2dWV4MWhkZ0k4RnZnVXhMZWRQb3U1ck1xWU9YNDRDZkRTUkFJNDJ3dEM5WFJWcWxPR3VqTVpjaGc?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Vertex Pharmaceuticals stock rallying today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSW1nRnNlajFzc2VkREJqbTJwV2pyNjd0UTdEcHlGblZEamltS0piMlAyRDBuTXA4ekVZVnpRbjRLQW04TjlaUWRnWndWYm9Bb2F3ZGI3cU5HQnd6Qk5kMk5WSVpUc1h0bVBMNDh4R0lXX3drNkVjSVFRNms0ZTFIM1p5NTVvTVJFa18zWHZPQWZIUm5UNE5LaXlNLXRjRXktQzFjMWVMZDN3T19LZnl2dA?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals EVP Joy Liu sells $469,222 in shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQd1BUaVF4Q3duR0RPQlI2TmtTcU5iS2huOUJKZm91ZEp6ZjRTcThTd0xiM1F5T2hVLW54ZHpsWF9aaVVHNkwxTzJOd2RqQ3cwNjEySTJSTDU1MHljZFRia2JXQ3RXd3dYaVAxN0pMRmZhejJDUVpMbFBjVjk0dkZYYXFaQW5IT1RlS1dkMkV4MzVFV0FYX2pFSzB0UnVrSHNGcG9UWnJmUS1RcC0tRXNpUXpTa1h4RGlCV0Zndko5MA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcHN0bzFPR2JFYWl4dnhFTDRTczh1LTZ4VnVZMnVvcFlyRHUydUxGSW8zUUl4RHB3dTlBd2dkLTlFS2pxOTBSTzhHd3dJdmM4T0prWXBXZXZTVzZldnM1Z3NwdFNObldvSmhtOGlFOXRDeF9RVzRfakdIOGJuc3VmNVZJeGJJemNXLVRBXzdxNlNjTGtZUFlDZVlpejRSanhYWTkza0lycjJxd1E?oc=5", "source_name": "IndexBox", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharma posts mixed Q1 results; Shares edge lower", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOLU5xNl9JNXNnNFFJNWtxNjdRSFROQnlhZnN0S1Fkd1drWWFGb1FXLXA4Qk1naTJSeTQxNHFURzdDMWh0amVTS3l0WVdPSHdnT2dzc0VFazZVbkFQdks2WTF1eGxwSm9pT2lpSEltT3FQUnFHQUNhT0hyWkJsam5fVl84dENxbjB3WVJoUzJwMTdtRllDQkE2VUhxd3RtWWFfeXdQNVYzXy1QemM?oc=5", "source_name": "Investing.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What to Expect From Vertex Pharmaceuticals\u2019 Q1 2026 Earnings Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPaDlwdnJpS3dqeVA5a3hpQUZoUHhkNGItLTRvN21LVTJmWnNpUl9La0NQc1pDTV9kVGlTTTllUmdOdjQ0bzdEQkJKVXlYYy01ZEdOS1REUW9ZUTgyMlZqZ0JwWW1ITExFSzlWSG02TDdSNk1ubHEwa3hiSzJzX2d3MllrcFAtV0JvMHJobmxFb2swcEZNcXFVdnRRWk5PRk4tcy1hRDdySWdsVXM4dnVF?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argus raises Vertex stock price target to $520 on CF franchise", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPdERMSmVmcWRudlgyNm5VcURWU2tkUFlhYWFmY0tFcUluNnpPQ012Sm5pdWdHcDFQLVJDVXlBZDdPQVZEaEZORzNjMzROdEpTcXE0WWtOaWNfQVRwSGEzYVo4RVNVcW9GTmxsUVNTY1AtRzdKYVZpUjNrWF9OZnpnSDdIMGVBUXJYc3hsRjlpbkdKUHozYVhTN0RUd0FFS1NmSlRFaV8wV0RvZ012VUFRTlFlRjhoWHduOVRNaVp3?oc=5", "source_name": "Investing.com", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital reiterates Vertex stock rating on competitive concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQbW5PMng3cWd5ekZkZ3NnNnBIamJlVElqT0Z2SVBCWVl3MDdpclZFT3pGbnVSd1BXWG5odlZfUHJNaWg5MDhQdm5MakZSdnE2bk81TWlHR0xYRk9HdGl5bUdONm1objk3cXluRzBQbXpxMGprcEJaSXo2QkZkU1ZqNWtwLUF1eXYyS3F0Ny1vMEw2V3M2NW9RYm1mLW1zbVczcGMzRFJOT19lUzdORzJvaU52ck83VFV0Z3dzbnBxR3JQVW0z?oc=5", "source_name": "Investing.com", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock Jumps with Positive Drug Pipeline News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPX1Z0eFhMcGFXeG1VeVBuZkYtQVR0NmlCZmlyUUFwOV9tdzlhV3NIUzZ6SWY1dC1seElmMF8yUzYyUk9NTkZES0tiNG9neHM1S0VuazdUc3labkVzUk9DMC1aWjJNd0pBX05ZTzZUNHh4VHVVdGNBQVE3ZzlIbmFjaVl0bThxdFVzXzJ1NGpJa1I2cjBaZ3FCOQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Duncan Mckechnie Sells Shares of Vertex Pharmaceuticals Inc (VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOenJUb19adXZRZFpxZ1lOVldBNENSUWRLaFc5SjRhcWF0TzJ4WmNBdldmcWd2YWMtVExaTk42aHdtcldSeUNOQVhfZ1hFR2tSTmMxLUw2NlN4VmdJZ0VTcnZTZ2xvbEk3Mi1pR2ZDLW9xOU5EeWpOYWVQZ1ZhUjhPd054Z0dXWlRwTlIxVXlKa0RMdG53OEtVNHEwMjBnRkZLeDlXamdrVDRMa1pUSDdiSml5a2pHZU9Yc2pEWmhMMGY5MHE5bEZN?oc=5", "source_name": "GuruFocus", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ambrose, Vertex Pharmaceuticals SVP, sells $108k in VRTX stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOMExaVEwyX3NRVFZVTUFSaFhBVTNLa2lnOG5OZ2I4bkFmTFdzZXBxeHdpWUpmN3B0d1ZSdTlSS0lWQWYwUkw4cTVNQ0llVFdGR3hFLXdCajl4TGt1VVQxb1I0VzdRZXZ1Skt3dlNwelVCZkNKZS1RbnRFYmtLSkVBQ2lnenAxQlA1d0pyYkxrenhrc2liZ1VoalBsVlZhWkNHRmhzRnZWUFkzWlROak5FU0pGUm9pRUtqaHRqX3l1UGhsQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) (NASDAQ:VRTX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMmxYWmJfSEZ6cHFraDJySHJPZzVJckFmYjBWZFVReDU3UXBva01yTU9hcWRLdVl3WnVUS1kxZENPNW1xR0t0Y05SRi1JYkg1VzM2ck55V0p6dzU5SGpuem1CcU1PSkZCcVByMVdjc0hQX3ZqTkVwX3M2Vlg5U3UzelkyM0thVGFmS0VaM01mTFZMRFhZWjRXWDFjbFVvdGpPM196bGl3U3VubjQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5", "source_name": "Investing.com", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOcGl1VW1CbE5Oc1h2cEhKNEU0cXhqX2sxdnhUVlRfZFROT1JXc2dDRzJ1M3JPckh4UzZWblFOeE5lNmhpQld5bDhXYTJvNGlXaTNQMjdXOVhSeS1jU045TzRkYV9WWnZaRnR1R1ppamxhbG14cjY0V2FOdzNRcGRkVGROcnJLYjQtRTBnUm5zd0gzY3BYYmtZVGRQLWlCVmZKWWk3UHdBYWZPZDNjOEhsZlVtSUlmQkxDUGo1czlwSlhBN0RNNXhV?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-10-24T07:00:00+00:00", "published_display": "24 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 19, "sentiment_summary": {"positive": 4, "negative": 5, "neutral": 10, "score": 49, "total": 19, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 621.43, "latest_week": "2026-07-10", "one_week_move": -10.0, "four_week_move": 10.1, "twelve_week_move": 12.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.7305, "market_dynamics_buy_signal": false, "relative_strength": -2.584039, "fair_value_gap": 6.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 59.8782, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.0% over one week, +10.1% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Investing.com", "count": 7}, {"label": "GuruFocus", "count": 4}, {"label": "Barchart.com", "count": 2}, {"label": "Investing.com Australia", "count": 2}, {"label": "IndexBox", "count": 1}, {"label": "timothysykes.com", "count": 1}, {"label": "Seeking Alpha", "count": 1}, {"label": "Fierce Pharma", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 19}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "19", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.0% over one week, +10.1% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Vertex Pharmaceuticals stock hits 52-week high at $507.98"}], "updated_at": "2026-07-17T21:31:46.531482+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}